|Former: Atención Farmacéutica|
|Journal edited by Rasgo Editorial since 1983|
Manuela Velázquez Prieto
EDITOR IN CHIEF
Jaime E. Poquet Jornet
Tomás Casasín Edo
Virginia Hernández Corredoira
Ramón Jódar Masanés
Juan Carlos Juárez Giménez
Volume 21 - Issue 1, January-February 2019
DRUG UTILIZATION STUDY AND PREVALENCE OF COGNITIVE DYSFUNCTION IN DIABETES MELLITUS
SHARMA AMIT, ARORA SIMRAN, GIL TARANPREET KAUR, MENGI ALEX, SODHI AMRITPAL, BALDI ASHISH, SHARMA DINESH KUMAR
Introduction. Drug utilization study acts as a powerful explanatory tool and is an ongoing, authorized and systemic quality improvement process for the health care decision. The process is used to ascertain the role of drugs in the society. The aim of the study is to evaluate the drug utilization pattern and prevalence of cognitive
dysfunction in diabetes mellitus (type 1 and type 2) patients.
Method. Prospective observational study including 205 patients was conducted for six months.
Results. Diabetes mellitus was found to be most prevalent (27.8%) in the age group of 51-60 years, more than half (56.1%) of the patients were males as compared to females (43.9%). It was analyzed that cognitive impairment most prevalently occurs in the geriatric patients who were having a score between 10-15 in
Conclusion. The diabetes was found to be more prevalent in males and there was moderate cognitive dysfunction in geriatric patients suffering from diabetes. Hence in future, improving the patient knowledge regarding the drug therapy, dose and frequency will perhaps improve the quality of life in diabetic patients.
COGNITIVE DYSFUNCTION (MMSE) PHQ-9 – DIABETES MELLITUS – DRUG UTILIZATION STUDIES